TW200740776A - N-phenylbenzotriazolyl c-kit inhibitors - Google Patents
N-phenylbenzotriazolyl c-kit inhibitorsInfo
- Publication number
- TW200740776A TW200740776A TW096104187A TW96104187A TW200740776A TW 200740776 A TW200740776 A TW 200740776A TW 096104187 A TW096104187 A TW 096104187A TW 96104187 A TW96104187 A TW 96104187A TW 200740776 A TW200740776 A TW 200740776A
- Authority
- TW
- Taiwan
- Prior art keywords
- phenylbenzotriazolyl
- kit inhibitors
- inhibitors
- kit
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77151906P | 2006-02-06 | 2006-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200740776A true TW200740776A (en) | 2007-11-01 |
Family
ID=38110706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW096104187A TW200740776A (en) | 2006-02-06 | 2007-02-05 | N-phenylbenzotriazolyl c-kit inhibitors |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20070232669A1 (zh) |
| AR (1) | AR059338A1 (zh) |
| TW (1) | TW200740776A (zh) |
| WO (1) | WO2007092403A1 (zh) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1392313B1 (en) * | 2001-05-16 | 2007-04-18 | Novartis AG | Combination comprising n- 5- 4-(4-methyl-piperazino-methyl)-benzoylamido|-2-methylphenyl -4-(3-pyridyl)-2pyrimidine-amine and a biphosphonate |
| GB201321740D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| EP3643711A1 (en) | 2018-10-24 | 2020-04-29 | Bayer Animal Health GmbH | New anthelmintic compounds |
| EP3942045A1 (en) | 2019-03-21 | 2022-01-26 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| CN114761006A (zh) | 2019-11-08 | 2022-07-15 | Inserm(法国国家健康医学研究院) | 对激酶抑制剂产生耐药性的癌症的治疗方法 |
| CR20220303A (es) | 2019-12-24 | 2022-09-02 | Gilead Sciences Inc | Compuestos moduladores de la diacilglicerol quinasa |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| WO2021163064A2 (en) | 2020-02-14 | 2021-08-19 | Jounce Therapeutics, Inc. | Antibodies and fusion proteins that bind to ccr8 and uses thereof |
| AU2022297367A1 (en) | 2021-06-23 | 2023-12-07 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| EP4359389A1 (en) | 2021-06-23 | 2024-05-01 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| CA3222439A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| CA3222277A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| US20230183216A1 (en) | 2021-10-28 | 2023-06-15 | Gilead Sciences, Inc. | Pyridizin-3(2h)-one derivatives |
| CA3235986A1 (en) | 2021-10-29 | 2023-05-04 | Gilead Science, Inc. | Cd73 compounds |
| US20240124412A1 (en) | 2021-12-22 | 2024-04-18 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
| AU2022417491A1 (en) | 2021-12-22 | 2024-05-23 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
| EP4245756B1 (en) | 2022-03-17 | 2024-10-09 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
| TW202400138A (zh) | 2022-04-21 | 2024-01-01 | 美商基利科學股份有限公司 | Ｋｒａｓ ｇ１２ｄ調節化合物 |
| US20240116928A1 (en) | 2022-07-01 | 2024-04-11 | Gilead Sciences, Inc. | Cd73 compounds |
| WO2024137852A1 (en) | 2022-12-22 | 2024-06-27 | Gilead Sciences, Inc. | Prmt5 inhibitors and uses thereof |
| WO2024215754A1 (en) | 2023-04-11 | 2024-10-17 | Gilead Sciences, Inc. | Kras modulating compounds |
| WO2024220917A1 (en) | 2023-04-21 | 2024-10-24 | Gilead Sciences, Inc. | Prmt5 inhibitors and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA82395C2 (en) * | 2003-08-21 | 2008-04-10 | Оси Фармасьютикалз, Инк. | N-substituted benzimidazolyl c-kit inhibitors |
| CN1839130A (zh) * | 2003-08-21 | 2006-09-27 | Osi制药公司 | N－取代的吡唑基－酰胺基－苯并咪唑基的c－kit抑制剂 |
-
2007
- 2007-02-05 TW TW096104187A patent/TW200740776A/zh unknown
- 2007-02-06 AR ARP070100490A patent/AR059338A1/es unknown
- 2007-02-06 WO PCT/US2007/003073 patent/WO2007092403A1/en active Application Filing
- 2007-02-06 US US11/702,767 patent/US20070232669A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AR059338A1 (es) | 2008-03-26 |
| WO2007092403A1 (en) | 2007-08-16 |
| US20070232669A1 (en) | 2007-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200740776A (en) | N-phenylbenzotriazolyl c-kit inhibitors | |
| TW200738725A (en) | Unsaturated mTOR inhibitors | |
| UA84712C2 (en) | N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors | |
| TW200519111A (en) | N3-substituted imidazopyridine C-KIT inhibitors | |
| MY146111A (en) | Acylaminopyrazoles as fgfr inhibitors | |
| TW200801006A (en) | Fused bicyclic mTOR inhibitors | |
| UA98141C2 (ru) | Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| TN2012000401A1 (en) | Heterocyclic compound | |
| EA200801428A1 (ru) | Производные пиридиазинона для лечения опухолей | |
| HK1139863A1 (en) | Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha | |
| GEP20084421B (en) | Proline derivatives and their use as dipeptidyl peptidase iv inhibitors | |
| MX2014001595A (es) | Compuestos de imidazol, composiciones y metodos de uso. | |
| MY158982A (en) | Heterocyclic compound | |
| SG178952A1 (en) | Chemical compounds | |
| MX2009009786A (es) | Inhibidores de la via de hedgehog. | |
| MX2008013582A (es) | Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa. | |
| HK1133012A1 (en) | Pyrimidinones as casein kinase ii (ck2) modulators | |
| TNSN08191A1 (en) | Kinase inhibitors | |
| MX2009003081A (es) | Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas. | |
| MY145795A (en) | Pyrazoline compounds | |
| MX2010004487A (es) | Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular. | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| MX2009012376A (es) | Derivados de pirimidona sustituidos con heteroarilamida para el tratamiento de enfermedades neurodegenerativas. | |
| TNSN08369A1 (en) | Benzimidazole derivatives |